Drugs / omega-3 plus
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT03147586 Comparator | Mar → Oct 2017 | infectious disease, urinary bladder cancer, urothelial carcinoma | Mansoura University | Unknown | No outcome recorded |
| Phase 4 | NCT01990690 Comparator | Jan → Jul 2015 | oligohydramnios | Woman's Health University Hospital, Egypt | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | omega-3 plus | “Group 1 was given omega -3 plus (Sedico medical company) as antioxidant once daily for two weeks.” NCT01990690 ↗ |